Artenimol

Artenimol

SCHEMBL21707299

C[C@H]1[C@@H](O)O[C@@H]2O[C@]3(C)CCC4[C@H](C)CC[C@@H]1[C@]42OO3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 9/20 1.00
ALDH1A1 P00352 4/20 1.00
LMNA P02545 3/20 1.00
HTT P42858 3/20 1.00
CYP3A4 P08684 2/20 1.00
TP53 P04637 1/20 1.00
SMN1; SMN2 Q16637 1/20 1.00
CYP1A2 P05177 2/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C19 P33261 1/20 0.56
HIF1A Q16665 1/20 0.56
NR1I2 O75469 1/20 0.56
CYP2B6 P20813 1/20 0.56
GAA P10253 1/20 0.56
HPGD P15428 1/20 0.56
HSD17B10 Q99714 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Artenimol SCHEMBL19937859 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP3A4
Artenimol SCHEMBL14552892 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP3A4
Artenimol SCHEMBL16404831 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP3A4
Artenimol SCHEMBL19236349 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP3A4
Artenimol SCHEMBL19600821 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP3A4
Artenimol SCHEMBL18421801 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP3A4
Artenimol SCHEMBL23843510 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP3A4
Artenimol SCHEMBL2132158 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP3A4
Artenimol SCHEMBL21707301 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP3A4
Artenimol SCHEMBL16638334 1.00 PTGES2 (1.00) PTGES2ALDH1A1LMNAHTTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11717508-B2 Compounds, compositions, and methods for inhibiting bacterial growth BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2023-08-08 US disclosed
US-11717508-B2 Compounds, compositions, and methods for inhibiting bacterial growth BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2023-08-08 US disclosed
US-20200046678-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR INHIBITING BACTERIAL GROWTH BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11717508-B2 Compounds, compositions, and methods for inhibiting bacterial growth LSS, PGLS, GLA PTGES2 873/4885ALDH1A1 2471/4885LMNA 1065/4885
US-20200046678-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR INHIBITING BACTERIAL GROWTH LSS, PGLS, GLA PTGES2 873/4885ALDH1A1 2471/4885LMNA 1065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.